EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PBAC : A pathway‐based attention convolution neural network for predicting clinical drug treatment responses

Dexun Deng, Xiaoqiang Xu, Ting Cui, Mingcong Xu, Kunpeng Luo, Han Zhang, Qiuyu Wang, Chao Song, Chao Li, Guohua Li, Desi Shang iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Dexun Deng und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China…. Hauptthemen laut MEDLINE: Neural Networks, Computer. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Research Foundation of the First Affiliated Hospital of University of South China for Advanced Talents, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precise and personalized drug application is crucial in the clinical treatment of complex diseases. Although neural networks offer a new approach to improving drug strategies, their internal structure is difficult to interpret. Here, we propose PBAC (Pathway‐Based Attention Convolution neural network), which integrates a deep learning framework and attention mechanism to address the complex biological pathway information, thereby provide a biology function‐based robust drug responsiveness prediction model. PBAC has four layers: gene‐pathway layer, attention layer, convolution layer and fully connected layer. PBAC improves the performance of predicting drug responsiveness by focusing on important pathways, helping us understand the mechanism of drug action in diseases. We validated the PBAC model using data from four chemotherapy drugs (Bortezomib, Cisplatin, Docetaxel and Paclitaxel) and 11 immunotherapy datasets. In the majority of datasets, PBAC exhibits superior performance compared to traditional machine learning methods and other research approaches (area under curve = 0.81, the area under the precision‐recall curve = 0.73). Using PBAC attention layer output, we identified some pathways as potential core cancer regulators, providing good interpretability for drug treatment prediction. In summary, we presented PBAC, a powerful tool to predict drug responsiveness based on the biology pathway information and explore the potential cancer‐driving pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neural Networks, ComputerHumansAntineoplastic AgentsNeoplasmsDeep LearningSignal TransductionComputational BiologyCisplatin

Stichwörter der Autor:innen

clinical treatmentdeep learningdrug treatment responseinterpretability

Substanzen

Antineoplastic AgentsCisplatin

Autor:innen und Institutionen

  • The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Hunan Provincial Key Laboratory of Multi-omics And Artificial Intelligence of Cardiovascular Diseases, University of South China, Hengyang, Hunan, China.
  • School of Computer, University of South China, Hengyang, Hunan, China.
  • The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Department of Cardiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
  • Department of Gastroenterology and Hepatology, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

ORCID-Profile: Desi Shang

Förderung

  • China Postdoctoral Science Foundation
  • Research Foundation of the First Affiliated Hospital of University of South China for Advanced Talents
  • Natural Science Foundation of Hunan Province
  • National Natural Science Foundation of China
  • Hengyang Science and Technology Plan Project
  • 2020 the Scientific Research Project of Hunan Provincial Department of Education

Zitieren

APA

Deng, D., Xu, X., Cui, T., Xu, M., Luo, K., Zhang, H., Wang, Q., Song, C., Li, C., Li, G., & Shang, D. (2024). PBAC : A pathway‐based attention convolution neural network for predicting clinical drug treatment responses. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18298

Vancouver

Deng D, Xu X, Cui T, Xu M, Luo K, Zhang H, et al. PBAC : A pathway‐based attention convolution neural network for predicting clinical drug treatment responses. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18298

BibTeX
@article{Deng2024,
  author = {Deng, Dexun and Xu, Xiaoqiang and Cui, Ting and Xu, Mingcong and Luo, Kunpeng and Zhang, Han and Wang, Qiuyu and Song, Chao and Li, Chao and Li, Guohua and Shang, Desi},
  title = {PBAC : A pathway‐based attention convolution neural network for predicting clinical drug treatment responses},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18298}
}
Kostenlos starten →